Daily Happy Hour Deals & Discounts: Shop now and save!
VANCOUVER, BC, August 16, 2017 – Deploy Technologies Inc. (CSE: DEP, OTC: DPLY) (“Deploy” or the “Company”) is pleased to announce that it has closed a second tranche of its previously announced private placement (the “Offering”), disclosed in the news release of the Company dated August 15, 2017, in connection with its proposed acquisition of Nevada Medical Group LLC (the “RTO”). The Company issued 2,607,655 subscription receipts (the “Subscription Receipts”) at a price of CDN $0.22 per Subscription Receipt (the “Purchase Price”) for aggregate gross proceeds of CDN $573,684.
The Company would like to correct the amount of subscription receipts issued and proceeds raised that were disclosed in the news release of the Company dated August 15, 2017 from 22,389,477 subscription receipts and aggregate proceeds of CDN $4,925,685 to 22,339,477 and CDN $4,914,685 respectively. For additional details on the first tranche of the private placement please reference the news released of the Company dated August 15, 2017.
In total, for the first and second tranche of the private placement, the Company has issued 24,947,132 Subscription Receipts for aggregate gross proceeds of CDN $5,488,369.
Deploy’s CEO, Dong Shim comments, “We are very pleased to have raised CDN $5,488,369 to date which currently satisfies a material condition precedent to the closing of the Acquisition of Nevada Medical Group by raising and exceeding the minimum of US $4,000,000 ($CDN equivalent today – $5,080,000). The Company wishes to thank all investors for their ongoing support as we continue through the Acquisition process. The Company anticipates raising additional funds through future tranches prior to the closing of the RTO.”
The RTO is subject to a number of conditions precedent, including CSE approval. The minimum financing requirement of US $4,000,000 pursuant to the terms of the RTO is calculable on closing of the RTO, and as such, the exchange rate as at the date of closing remains unknown.
In connection with the second tranche, CDN $19,247 and 87,488 compensation warrants were issued to eligible finders as payment of half of the finders’ fees due to such finders for the introduction of subscribers to the Company. For more information on the terms of the finders fees please see the Company’s news release dated August 15, 2017.
All securities issued pursuant to the Offering, including the Underlying Securities and all shares issuable pursuant to the exercise of Compensation Warrants, will be subject to a four month and one day hold from the date of issuance of the Subscription Receipts.
The Company will use the net proceeds of the Offering to complete the RTO and for general working capital purposes of the resulting issuer.
For further information please contact:
Darren Tindale, CFO Deploy Technologies Inc.
Email: stonerockltd@gmail.com
Completion of the RTO is subject to a number of conditions, including receipt of appropriate regulatory approvals. The RTO cannot close until all such conditions are satisfied. There can be no assurance that the RTO will be completed as proposed or at all.
Investors are cautioned that, except as disclosed in the disclosure document to be prepared in connection with the transaction, any information released or received with respect to the Acquisition may not be accurate or complete and should not be relied upon. Trading in securities of Deploy Technologies Inc. should be considered highly speculative.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors – including the availability of funds, the results of financing efforts and the parties’ due diligence reviews, and general market conditions – that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
We seek safe harbour.
Stay up to date with the latest video business news, strategies, and insights sent straight to your inbox!
Las Vegas, NV and Vancouver, B.C., Canada (June 21, 2024) – Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operations-focused cannabis company, is pleased to announce its financial results for the third quarter of fiscal year 2024 ended April 30, 2024, and to provide shareholders with an operational update.…
Las Vegas, NV and Vancouver, B.C., Canada (March 26, 2024) – Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operations-focused cannabis company, is pleased to announce its financial results for the second quarter of fiscal year 2024 ended January 31, 2024 and to provide shareholders with an operational update.…
Las Vegas, NV and Vancouver, B.C., Canada (February 1, 2024) – Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operations-focused cannabis company, is pleased to announce updates on its dispensary development schedules and the divestment of the Company’s cultivation and processing operations in Nevada, which is owned through the…